Lexaria Bioscience Corp. — Director's Dealing 2015

Jun 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-24	Common Shares	P	10000	$0.19	Acquired	4156580	Direct
2015-06-24	Common Shares	P	5000	$0.156	Acquired	4161580	Direct
2015-06-24	Common Shares	P	10000	$0.156	Acquired	4171580	Direct
2015-06-24	Common Shares	P	20000	$0.157	Acquired	4191580	Direct
2015-06-24	Common Shares	P	20000	$0.155	Acquired	4211580	Direct
2015-06-24	Common Shares	P	10000	$0.155	Acquired	4221580	Direct
2015-06-24	Common Shares	P	20000	$0.157	Acquired	4241580	Direct
2015-06-24	Common Shares	P	5000	$0.158	Acquired	4246580	Direct
2015-06-24	Common Shares	P	35600	$0.15	Acquired	4282180	Direct
2015-06-24	Common Shares	P	5100	$0.149	Acquired	4287280	Direct
2015-06-24	Common Shares	P	10000	$0.158	Acquired	4297280	Direct
2015-06-24	Common Shares	P	10000	$0.158	Acquired	4307280	Direct
2015-06-24	Common Shares	P	20000	$0.158	Acquired	4327280	Direct
2015-06-24	Common Shares	P	17000	$0.155	Acquired	4344280	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	4146580	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2015-09-21	Common Shares (100067)	1025067	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect

Footnotes

F1: Purchase price was in Canadian Funds